News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid

The NIH’s tech transfer community is pursuing new law firm contracts for managing patent prosecution matters as the current contracts end Spring of 2019. As part of the development for the new Request For Proposals (RFP), the community is providing the public with the chance to comment or ask

Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won the 2018 António Champalimaud Vision Award, a 1 million euro prize from Portugal’s Champalimaud Foundation. Among them is Michael Redmond